Yoda Pharmaceuticals Inc. (TPEX:7829)
Taiwan · Delayed Price · Currency is TWD 51.00
+0.80 (1.59%)
At close: Oct 20, 2026
Yoda Pharmaceuticals Market Cap
Yoda Pharmaceuticals has a market cap or net worth of 5.07 billion as of October 20, 2026. It is the 22,404th most valuable company in the world and the 1,102nd biggest in Taiwan. Its market cap has increased by 1.51% in one year.
Market Cap
5.07B
Enterprise Value
3.43B
Revenue
n/a
Global Rank
Country Rank
#1,102 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since June 3, 2025, Yoda Pharmaceuticals's market cap has increased from 2.92B to 5.07B, an increase of 73.74%. That is a compound annual growth rate of 49.19%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 20, 2026 | 5.07B | 8.96% |
| Dec 31, 2025 | 4.65B | 59.46% |
| Jun 3, 2025 | 2.92B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SCI Pharmtech | 6.26B |
| Orient Pharma | 5.87B |
| Alar Pharmaceuticals | 5.74B |
| Formosa Laboratories | 5.56B |
| Panion & Bf Biotech | 4.56B |
| LIWANLI Innovation | 4.45B |
| Orient EuroPharma | 3.97B |
| Easywell Biomedicals | 3.50B |